Alabama Litigation Review

Alabama Litigation Review

Insights & Commentary on Developments in Alabama Litigation

Tag Archives: mass tort

Injury Cases Involving Atrium C-Qur Hernia Mesh Continue To Progress

Posted in Defective Products
At the Blackwell Law Firm website we have a section called Hot Topics. That section provides news and research related to current legal issues. Many of these issues involve injury from bad drugs or dangerous medical devices. Among those topics — two hernia mesh products. These are Ethicon’s Physiomesh and Atrium’s C-Qur mesh. We are currently… Continue Reading

Does The Drug Abilify Cause Compulsive Behaviors?

Posted in Defective Products
It’s difficult to believe. Like many people, I had serious doubts. Very serious doubts. Can a drug really cause compulsive behaviors like uncontrollable gambling? Many Abilify victims suffered the doubts of family and friends. Yet, new medical research now supports a link between the drug and these dangerous compulsive behaviors. WHAT IS ABILIFY? The Food… Continue Reading

Diversity Jurisdiction: Speculation On The Amount In Controversy

Posted in Federal Courts
I have not discussed Federal court diversity jurisdiction in a long time. Yet, the issue is important for attorneys handling significant injury claims. A SHORT DEFINITION OF FEDERAL COURT DIVERSITY JURISDICTION Federal courts are courts of limited jurisdiction. Generally, Federal courts have jurisdiction of claims under the U.S. Constitution, treaties and Federal statutes. Federal law… Continue Reading

New Anticoagulants Continue To Raise Safety Issues

Posted in Defective Products, Personal Injury
In September, I discussed new anticoagulants Xarelto and Eliquis. My prior post concludes by noting patients deserve drugs approved only after careful study for safety. Shortly after that post, the ISMP Quarterwatch also raised issues concerning the safety of new anticoagulants rivaroxaban (Xarelto), dabigatron (Pradaxa), and apixaban (Eliquis). According to Quarterwatch: The adverse event reports for oral… Continue Reading

Invokana And The Risk Of Bone Fractures

Posted in Defective Products
Is Invokana (canagliflozin) a dangerous and defective drug? In a prior post, I discussed the history of Invokana and its link to ketoacidosis. Ketoacidosis can be a life-threatening condition caused by a build-up of acid in the blood. Now, the FDA has issued a new Invokana safety warning. According to the new FDA safety alert:… Continue Reading

First Pradaxa. Then Xarelto. Now Eliquis?

Posted in Defective Products, Personal Injury
Will Eliquis join Pradaxa and Xarelto as another anti-coagulant drug facing claims of severe internal bleeding? Pradaxa was the first of these three new anti-coagulants (blood thinners). It hit the market in 2010. Sales quickly boomed. However, adverse reports of severe internal hemorrhaging and bleeding soon followed. In May 2014, Pradaxa’s manufacturer settled about 4,000… Continue Reading

Invokana – Is The Drug A Safe Treatment For Diabetes?

Posted in Defective Products, Personal Injury
Invokana (canagliflozin) is a relatively new drug marketed to treat Type 2 diabetes. The drug is the first in a new class of medications known as sodium-glucose cotransporter 2 (SGLT2) inhibitors. This class of drugs also includes Farxiga, Glyxambi, Jardiance, and Xigduo XR. How does this new class of drugs work? The drugs work by altering… Continue Reading

Mesh: Concerns and Questions

Posted in Defective Products
Transvaginal mesh and its complications made headlines this week as a jury reached a $3.35 million compensatory damages verdict in a New Jersey Court, with punitive damages to follow. This bold action ignites concern and questions for thousands of other women implanted with the same device. What is transvaginal mesh? Transvaginal mesh is a medical… Continue Reading

Alabama Will Receive Share of Record Drug Company Fine

Posted in Defective Products, Personal Injury
Drug maker GlaxoSmithKline (Glaxo) will pay a record $3 Billion criminal fraud settlement with the government as a result of its deceptive sales practices. The criminal charges accused Glaxo of practices which pushed dangerous medications on the American public. According to the news, the State of Alabama will receive almost $6 Million of the proceeds.… Continue Reading

Whistleblower Files Suit Against Takeda Over Actos

Posted in Defective Products
Actos litigation is a subject that I have addressed on several occasions. The pending claims continue to move forward. As they progress, we learn more about the manufacturer Takeda’s research and marketing of this diabetes drug to the public. Last week, Bloomberg revealed that a whistleblower has also filed suit against Actos manufacturer Takeda. Add… Continue Reading

Update — Consolidation of Defective Mesh Claims Against Boston Scientific

Posted in Defective Products
A couple weeks ago, the U.S. Judicial Panel on Multidistrict Litigation (JPML) met in Miami to discuss the consolidation of claims against several transvaginal mesh manufacturers. I previously wrote about this issue. Today, the JPML issued its decision. As requested by many of the plaintiffs, the Court has consolidated the pre-trial proceedings in the Southern… Continue Reading

Actos Update – MDL Panel Consolidates Cases

Posted in Defective Products
The Federal Judicial Panel on Multidistrict Litigation has issued its Order consolidating all pending Actos cases in Federal Court. The cases have been consolidated before U.S. District Judge Rebecca Doherty in the U.S. District Court for the Western District of Louisiana. This means that Judge Doherty will preside over all the pretrial proceedings in these… Continue Reading

Type 2 Diabetes, Actos, and Bladder Cancer

Posted in Defective Products
Many adults are impacted by Type 2 diabetes (sometimes referred to as adult-onset diabetes or non insulin-dependent diabetes).  Type 2 diabetes is a chronic condition that affects the way your body metabolizes sugar.  Left untreated it can be life-threatening.  However, the condition can be managed.  Often, it can be managed through diet and exercise.  Unfortunately,… Continue Reading

Our Courts Continue to Allow Foreign Manufacturers to Escape Justice

Posted in Defective Products
Yesterday, I read a blog post by Mobile, Alabama attorney Edwin Lamberth.  Edwin’s blog is always a great source of commentary.  Edwin’s recent post discusses an important issue – foreign companies not being held accountable for the injuries and deaths caused by their defective and dangerous products. This is a subject I’ve previously addressed as… Continue Reading